Controlled release formulations (CRFs) are a key technical approach for the sustainable development of pesticides. In this study, a CRF conjugate (emamectin-alkaline lignin, EB-AL) was successfully prepared using alkaline lignin as the substrate, with amide bond connecting emamectin and alkaline lignin. The structure and morphology of the conjugate were characterized using IR, 1HNMR, elemental analysis, SEM and TG. The release of EB-AL showed that the conjugate maintained its original structure when released in 50 % methanol-water and soil column, and the amide bond remained intact. The anti-photolysis test revealed that EB-AL had a 3.5 times higher photolysis half-life T0.5 than the general emamectin suspension concentrate (EB-SC). Bioactivity tests in the greenhouse demonstrated that EB-AL possessed a longer insecticidal duration and good biosafety. Ostrinia nubilalis lethality rate remained above 70 % for 19 days, while EB-EC, the control, had a rate of <50 % after 11 days of application. Additionally, EB-AL conjugate demonstrated excellent systemic translocation in plants, likely due to its ability to mediate alkaline lignin.
Keywords: Alkaline lignin; Emamectin benzoate; Emamectin-alkaline lignin conjugate; Photolysis resistance; Systemic translocation.
Copyright © 2023 Elsevier B.V. All rights reserved.